iShares NASDAQ US Biotechnology UCITS ETF (SWX:BTEC)
Switzerland · Delayed Price · Currency is CHF · Price in USD 6.50
+0.05 (0.84%)
At close: Aug 8, 2025, 5:20 PM CET
SWX:BTEC Holdings Information
SWX:BTEC is an equity ETF with a total of 264 individual holdings. The top holdings are Gilead Sciences stock at 7.56%, Amgen at 7.24%, Vertex Pharmaceuticals at 6.24%, Regeneron Pharmaceuticals at 6.14%, and Alnylam Pharmaceuticals at 5.31%.
Total Holdings
264
Top 10 Percentage
45.76%
Asset Class
Equity
ETF Category
Health Care
Assets
445.43M
PE Ratio
n/a
Sector Allocation
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | GILD | Gilead Sciences, Inc. | 7.56% |
| 2 | AMGN | Amgen Inc. | 7.24% |
| 3 | VRTX | Vertex Pharmaceuticals Incorporated | 6.24% |
| 4 | REGN | Regeneron Pharmaceuticals, Inc. | 6.14% |
| 5 | ALNY | Alnylam Pharmaceuticals, Inc. | 5.31% |
| 6 | AZN | AstraZeneca PLC | 4.79% |
| 7 | INSM | Insmed Incorporated | 2.37% |
| 8 | ARGX | argenx SE | 2.12% |
| 9 | BIIB | Biogen Inc. | 2.08% |
| 10 | SMMT | Summit Therapeutics Inc. | 1.92% |
| 11 | INCY | Incyte Corporation | 1.68% |
| 12 | ILMN | Illumina, Inc. | 1.64% |
| 13 | RPRX | Royalty Pharma plc | 1.54% |
| 14 | UTHR | United Therapeutics Corporation | 1.44% |
| 15 | SNY | Sanofi | 1.44% |
| 16 | MEDP | Medpace Holdings, Inc. | 1.35% |
| 17 | NBIX | Neurocrine Biosciences, Inc. | 1.34% |
| 18 | ONC | BeOne Medicines Ltd. | 1.32% |
| 19 | VTRS | Viatris Inc. | 1.28% |
| 20 | TEM | Tempus AI, Inc. | 1.25% |
| 21 | ASND | Ascendis Pharma A/S | 1.20% |
| 22 | BNTX | BioNTech SE | 1.13% |
| 23 | BMRN | BioMarin Pharmaceutical Inc. | 1.12% |
| 24 | MRNA | Moderna, Inc. | 1.10% |
| 25 | EXEL | Exelixis, Inc. | 1.04% |
As of Aug 19, 2025